APA (7th ed.) Citation

K, V., O, B., S, W., A, T., B, C., C, V., . . . B, L. (2025). Budget impact analysis of cenobamate, a novel adjunctive therapy for the treatment of drug resistant focal onset seizures, from the Belgian healthcare payer perspective. Journal of medical economics, 28(1), 990. https://doi.org/10.1080/13696998.2025.2520182

Chicago Style (17th ed.) Citation

K, Vonck, Bodart O, Weckhuysen S, Tanghe A, Callebaut B, Verdonck C, Van den Bergh L, and Legros B. "Budget Impact Analysis of Cenobamate, a Novel Adjunctive Therapy for the Treatment of Drug Resistant Focal Onset Seizures, from the Belgian Healthcare Payer Perspective." Journal of Medical Economics 28, no. 1 (2025): 990. https://doi.org/10.1080/13696998.2025.2520182.

MLA (9th ed.) Citation

K, Vonck, et al. "Budget Impact Analysis of Cenobamate, a Novel Adjunctive Therapy for the Treatment of Drug Resistant Focal Onset Seizures, from the Belgian Healthcare Payer Perspective." Journal of Medical Economics, vol. 28, no. 1, 2025, p. 990, https://doi.org/10.1080/13696998.2025.2520182.